Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention

@article{Fujiwara2015Lower1I,
  title={Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention},
  author={Takayuki Fujiwara and Masashi Yoshida and Naoyuki Akashi and Hodaka Yamada and Takunori Tsukui and Tomohiro Nakamura and Kenichi Sakakura and Hiroshi Wada and Kenshiro Arao and Takuji Katayama and Tomio Umemoto and Hiroshi Funayama and Yoshitaka Sugawara and Takeshi Mitsuhashi and Masafumi Kakei and Shin-ichi Momomura and Junya Ako},
  journal={Heart and Vessels},
  year={2015},
  volume={31},
  pages={855-862}
}
Diabetes mellitus and impaired glucose tolerance are well-known risk factors for coronary artery disease (CAD) and adverse clinical events after percutaneous coronary intervention (PCI). Postprandial hyperglycemia is an important risk factor for CAD and serum 1,5-anhydroglucitol (1,5-AG) reflects postprandial hyperglycemia more robustly than hemoglobin (Hb)A1c. We aimed to clarify the relationship between serum 1,5-AG level and adverse clinical events after PCI. We enrolled 141 patients after… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

The prognostic significance of the degree of coronary stenosis

P Harris, M Conley, V Behar, R Rosat
  • Am J Cardiol
  • 1979
VIEW 13 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…